BMY logo

Bristol-Myers Squibb (BMY) Cash From Operations

Annual CFO

$13.86 B
+$794.00 M+6.08%

31 December 2023

BMY Cash From Operations Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFO

$5.59 B
+$3.27 B+140.37%

30 September 2024

BMY Quarterly CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFO

$15.00 B
+$840.00 M+5.93%

30 September 2024

BMY TTM CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BMY Cash From Operations Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.1%+17.7%+16.2%
3 y3 years-1.4%+6.2%-3.2%
5 y5 years+96.2%+118.7%+56.5%

BMY Cash From Operations High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-14.5%+6.1%at high+196.3%-7.4%+26.6%
5 y5 years-14.5%+96.2%at high+196.3%-7.4%+82.7%
alltimeall time-14.5%+1366.7%at high+614.8%-7.4%+3817.2%

Bristol-Myers Squibb Cash From Operations History

DateAnnualQuarterlyTTM
Sept 2024
-
$5.59 B(+140.4%)
$15.00 B(+5.9%)
June 2024
-
$2.33 B(-17.9%)
$14.16 B(+3.2%)
Mar 2024
-
$2.83 B(-33.3%)
$13.72 B(-1.0%)
Dec 2023
$13.86 B(+6.1%)
$4.25 B(-10.5%)
$13.86 B(+7.3%)
Sept 2023
-
$4.75 B(+151.8%)
$12.91 B(+9.0%)
June 2023
-
$1.89 B(-36.5%)
$11.85 B(-3.1%)
Mar 2023
-
$2.97 B(-10.2%)
$12.22 B(-6.4%)
Dec 2022
$13.07 B(-19.4%)
$3.31 B(-10.3%)
$13.07 B(-5.4%)
Sept 2022
-
$3.69 B(+63.1%)
$13.82 B(-10.3%)
June 2022
-
$2.26 B(-40.7%)
$15.40 B(-4.9%)
Mar 2022
-
$3.81 B(-6.0%)
$16.20 B(-0.1%)
Dec 2021
$16.21 B(+15.3%)
$4.06 B(-23.0%)
$16.21 B(+4.5%)
Sept 2021
-
$5.27 B(+72.1%)
$15.51 B(+24.0%)
June 2021
-
$3.06 B(-20.0%)
$12.51 B(-10.3%)
Mar 2021
-
$3.82 B(+14.0%)
$13.94 B(-0.8%)
Dec 2020
$14.05 B(+71.2%)
$3.35 B(+48.0%)
$14.05 B(+9.1%)
Sept 2020
-
$2.27 B(-49.5%)
$12.88 B(-2.2%)
June 2020
-
$4.49 B(+14.1%)
$13.17 B(+22.4%)
Mar 2020
-
$3.94 B(+80.5%)
$10.76 B(+31.0%)
Dec 2019
$8.21 B(+16.2%)
$2.18 B(-14.7%)
$8.21 B(-14.3%)
Sept 2019
-
$2.56 B(+22.7%)
$9.58 B(+15.4%)
June 2019
-
$2.08 B(+49.9%)
$8.31 B(+14.1%)
Mar 2019
-
$1.39 B(-60.9%)
$7.28 B(+3.0%)
Dec 2018
$7.07 B(+34.0%)
$3.56 B(+178.0%)
$7.07 B(+52.7%)
Sept 2018
-
$1.28 B(+21.0%)
$4.63 B(-8.6%)
June 2018
-
$1.06 B(-10.0%)
$5.06 B(-9.4%)
Mar 2018
-
$1.18 B(+5.2%)
$5.59 B(+6.0%)
Dec 2017
$5.28 B(+72.5%)
$1.12 B(-34.8%)
$5.28 B(-5.8%)
Sept 2017
-
$1.71 B(+8.1%)
$5.60 B(+5.8%)
June 2017
-
$1.58 B(+84.0%)
$5.29 B(+27.6%)
Mar 2017
-
$861.00 M(-40.3%)
$4.15 B(+35.6%)
Dec 2016
$3.06 B(+45.3%)
$1.44 B(+2.8%)
$3.06 B(+22.4%)
Sept 2016
-
$1.40 B(+219.8%)
$2.50 B(+54.4%)
June 2016
-
$439.00 M(-292.5%)
$1.62 B(+29.4%)
Mar 2016
-
-$228.00 M(-125.8%)
$1.25 B(-40.6%)
Dec 2015
$2.10 B(-33.1%)
$884.00 M(+68.7%)
$2.10 B(+17.4%)
Sept 2015
-
$524.00 M(+638.0%)
$1.79 B(-17.4%)
June 2015
-
$71.00 M(-88.7%)
$2.17 B(-31.2%)
Mar 2015
-
$626.00 M(+9.4%)
$3.16 B(+0.3%)
Dec 2014
$3.15 B(-11.2%)
$572.00 M(-36.7%)
$3.15 B(-21.0%)
Sept 2014
-
$903.00 M(-14.5%)
$3.99 B(-3.6%)
June 2014
-
$1.06 B(+71.2%)
$4.14 B(-9.9%)
Mar 2014
-
$617.00 M(-56.2%)
$4.59 B(+29.5%)
Dec 2013
$3.54 B(-48.9%)
$1.41 B(+33.9%)
$3.54 B(+19.3%)
Sept 2013
-
$1.05 B(-30.3%)
$2.97 B(-54.3%)
June 2013
-
$1.51 B(-452.8%)
$6.50 B(+6.1%)
Mar 2013
-
-$428.00 M(-151.2%)
$6.13 B(-11.7%)
Dec 2012
$6.94 B(+43.4%)
$836.00 M(-81.8%)
$6.94 B(-9.5%)
Sept 2012
-
$4.58 B(+304.2%)
$7.67 B(+60.3%)
June 2012
-
$1.13 B(+193.0%)
$4.79 B(+0.9%)
Mar 2012
-
$387.00 M(-75.3%)
$4.75 B(-1.9%)
Dec 2011
$4.84 B(+7.8%)
$1.57 B(-7.7%)
$4.84 B(-0.6%)
Sept 2011
-
$1.70 B(+55.4%)
$4.87 B(+6.9%)
June 2011
-
$1.09 B(+127.2%)
$4.55 B(+1.0%)
Mar 2011
-
$481.00 M(-69.8%)
$4.51 B(+0.4%)
Dec 2010
$4.49 B(+10.5%)
$1.59 B(+15.3%)
$4.49 B(+5.9%)
Sept 2010
-
$1.38 B(+31.8%)
$4.24 B(-2.1%)
June 2010
-
$1.05 B(+126.1%)
$4.33 B(+6.2%)
Mar 2010
-
$464.00 M(-65.5%)
$4.08 B(+0.3%)
Dec 2009
$4.07 B(+9.7%)
$1.34 B(-8.8%)
$4.07 B(+31.7%)
Sept 2009
-
$1.47 B(+85.1%)
$3.09 B(+0.7%)
June 2009
-
$796.00 M(+76.1%)
$3.07 B(-9.4%)
Mar 2009
-
$452.00 M(+23.5%)
$3.38 B(-8.7%)
Dec 2008
$3.71 B(+17.6%)
$366.00 M(-74.8%)
$3.71 B(-6.6%)
Sept 2008
-
$1.45 B(+30.3%)
$3.97 B(+23.5%)
June 2008
-
$1.11 B(+43.7%)
$3.22 B(+1.7%)
Mar 2008
-
$775.00 M(+23.0%)
$3.16 B(+0.3%)
Dec 2007
$3.15 B
$630.00 M(-9.6%)
$3.15 B(+15.3%)
Sept 2007
-
$697.00 M(-34.3%)
$2.73 B(-8.3%)
June 2007
-
$1.06 B(+38.7%)
$2.98 B(+7.8%)
DateAnnualQuarterlyTTM
Mar 2007
-
$765.00 M(+262.6%)
$2.77 B(+32.7%)
Dec 2006
$2.08 B(+13.5%)
$211.00 M(-77.6%)
$2.08 B(-4.0%)
Sept 2006
-
$944.00 M(+11.7%)
$2.17 B(+9.3%)
June 2006
-
$845.00 M(+918.1%)
$1.99 B(+74.7%)
Mar 2006
-
$83.00 M(-72.1%)
$1.14 B(-38.1%)
Dec 2005
$1.84 B(-42.2%)
$297.00 M(-60.9%)
$1.84 B(-17.4%)
Sept 2005
-
$760.00 M(<-9900.0%)
$2.22 B(+8.8%)
June 2005
-
-$4.00 M(-100.5%)
$2.04 B(-29.0%)
Mar 2005
-
$783.00 M(+14.6%)
$2.88 B(-9.4%)
Dec 2004
$3.18 B(-9.6%)
$683.00 M(+17.6%)
$3.18 B(-15.2%)
Sept 2004
-
$581.00 M(-30.1%)
$3.74 B(-9.0%)
June 2004
-
$831.00 M(-23.1%)
$4.11 B(-7.2%)
Mar 2004
-
$1.08 B(-13.6%)
$4.43 B(+26.2%)
Dec 2003
$3.51 B(+271.6%)
$1.25 B(+31.5%)
$3.51 B(+19.1%)
Sept 2003
-
$951.00 M(-17.3%)
$2.95 B(+0.5%)
June 2003
-
$1.15 B(+618.8%)
$2.94 B(+34.0%)
Mar 2003
-
$160.00 M(-76.7%)
$2.19 B(+131.9%)
Dec 2002
$945.00 M(-82.5%)
$688.00 M(-26.6%)
$945.00 M(-57.5%)
Sept 2002
-
$937.00 M(+130.8%)
$2.22 B(-5.0%)
June 2002
-
$406.00 M(-137.4%)
$2.34 B(-32.1%)
Mar 2002
-
-$1.09 B(-155.2%)
$3.45 B(-36.2%)
Dec 2001
$5.40 B(+16.1%)
$1.97 B(+86.7%)
$5.40 B(+2.8%)
Sept 2001
-
$1.05 B(-30.4%)
$5.26 B(-2.5%)
June 2001
-
$1.51 B(+74.2%)
$5.39 B(+12.0%)
Mar 2001
-
$869.00 M(-52.3%)
$4.82 B(+3.5%)
Dec 2000
$4.65 B(+10.1%)
$1.82 B(+53.2%)
$4.65 B(+6.2%)
Sept 2000
-
$1.19 B(+26.7%)
$4.38 B(+2.3%)
June 2000
-
$938.00 M(+32.9%)
$4.28 B(+1.7%)
Mar 2000
-
$706.00 M(-54.5%)
$4.21 B(-0.4%)
Dec 1999
$4.22 B(+11.7%)
$1.55 B(+42.5%)
$4.22 B(+11.8%)
Sept 1999
-
$1.09 B(+25.8%)
$3.78 B(-5.8%)
June 1999
-
$865.00 M(+20.0%)
$4.01 B(+10.7%)
Mar 1999
-
$721.00 M(-34.8%)
$3.62 B(-4.2%)
Dec 1998
$3.78 B(+52.7%)
$1.10 B(-16.2%)
$3.78 B(+15.7%)
Sept 1998
-
$1.32 B(+175.9%)
$3.27 B(+17.8%)
June 1998
-
$478.00 M(-45.7%)
$2.78 B(+4.0%)
Mar 1998
-
$880.00 M(+48.4%)
$2.67 B(+7.8%)
Dec 1997
$2.48 B(-6.2%)
$593.00 M(-28.1%)
$2.48 B(-2.6%)
Sept 1997
-
$825.00 M(+122.4%)
$2.54 B(+3.4%)
June 1997
-
$371.00 M(-46.0%)
$2.46 B(-9.4%)
Mar 1997
-
$687.00 M(+4.4%)
$2.71 B(+2.7%)
Dec 1996
$2.64 B(+5.7%)
$658.00 M(-11.3%)
$2.64 B(+0.6%)
Sept 1996
-
$742.00 M(+18.5%)
$2.63 B(-0.9%)
June 1996
-
$626.00 M(+1.8%)
$2.65 B(+12.2%)
Mar 1996
-
$615.00 M(-4.2%)
$2.36 B(-5.5%)
Dec 1995
$2.50 B(+8.6%)
$642.00 M(-16.3%)
$2.50 B(-0.5%)
Sept 1995
-
$767.00 M(+127.6%)
$2.51 B(+12.7%)
June 1995
-
$337.00 M(-55.2%)
$2.23 B(-5.5%)
Mar 1995
-
$753.00 M(+15.0%)
$2.36 B(+2.5%)
Dec 1994
$2.30 B(-10.8%)
$655.00 M(+35.3%)
$2.30 B(-4.5%)
Sept 1994
-
$484.00 M(+3.9%)
$2.41 B(-11.8%)
June 1994
-
$466.00 M(-33.0%)
$2.73 B(-4.5%)
Mar 1994
-
$696.00 M(-8.9%)
$2.86 B(+11.0%)
Dec 1993
$2.58 B(+27.2%)
$764.00 M(-5.3%)
$2.58 B(+4.9%)
Sept 1993
-
$807.00 M(+35.4%)
$2.46 B(+5.1%)
June 1993
-
$596.00 M(+44.3%)
$2.34 B(+14.6%)
Mar 1993
-
$413.00 M(-35.9%)
$2.04 B(+0.7%)
Dec 1992
$2.03 B(+10.5%)
$644.00 M(-6.4%)
$2.03 B(-0.8%)
Sept 1992
-
$688.00 M(+130.9%)
$2.04 B(+10.0%)
June 1992
-
$298.00 M(-25.1%)
$1.86 B(-0.1%)
Mar 1992
-
$398.00 M(-39.7%)
$1.86 B(+1.4%)
Dec 1991
$1.83 B(+4.7%)
$660.00 M(+31.2%)
$1.83 B(+6.9%)
Sept 1991
-
$503.00 M(+67.7%)
$1.72 B(+3.7%)
June 1991
-
$300.00 M(-19.4%)
$1.65 B(-5.0%)
Mar 1991
-
$372.00 M(-31.2%)
$1.74 B(-0.6%)
Dec 1990
$1.75 B(+47.2%)
$541.00 M(+22.7%)
$1.75 B(+44.7%)
Sept 1990
-
$441.00 M(+14.0%)
$1.21 B(+57.3%)
June 1990
-
$387.00 M(+1.0%)
$770.00 M(+101.0%)
Mar 1990
-
$383.00 M
$383.00 M
Dec 1989
$1.19 B
-
-

FAQ

  • What is Bristol-Myers Squibb annual cash flow from operations?
  • What is the all time high annual CFO for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb annual CFO year-on-year change?
  • What is Bristol-Myers Squibb quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb quarterly CFO year-on-year change?
  • What is Bristol-Myers Squibb TTM cash flow from operations?
  • What is the all time high TTM CFO for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb TTM CFO year-on-year change?

What is Bristol-Myers Squibb annual cash flow from operations?

The current annual CFO of BMY is $13.86 B

What is the all time high annual CFO for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high annual cash flow from operations is $16.21 B

What is Bristol-Myers Squibb annual CFO year-on-year change?

Over the past year, BMY annual cash flow from operations has changed by +$794.00 M (+6.08%)

What is Bristol-Myers Squibb quarterly cash flow from operations?

The current quarterly CFO of BMY is $5.59 B

What is the all time high quarterly CFO for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high quarterly cash flow from operations is $5.59 B

What is Bristol-Myers Squibb quarterly CFO year-on-year change?

Over the past year, BMY quarterly cash flow from operations has changed by +$840.00 M (+17.68%)

What is Bristol-Myers Squibb TTM cash flow from operations?

The current TTM CFO of BMY is $15.00 B

What is the all time high TTM CFO for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high TTM cash flow from operations is $16.21 B

What is Bristol-Myers Squibb TTM CFO year-on-year change?

Over the past year, BMY TTM cash flow from operations has changed by +$2.09 B (+16.18%)